Aoxing Pharmaceutical Company Inc.
AXN
AXN was delisted on the 16th of October, 2017.
6 hedge funds and large institutions have $195K invested in Aoxing Pharmaceutical Company Inc. in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
1,673% more capital invested
Capital invested by funds: $11K → $195K (+$184K)
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
100% more funds holding
Funds holding: 3 → 6 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$43.4K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$28.4K |
| 3 |
Goldman Sachs
New York
|
+$13.4K |
| 4 |
Renaissance Technologies
New York
|
+$10.5K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$73 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VKH
1
Virtu KCG Holdings
New York
| $79K | +$43.4K | +46,541 | New |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $51K | +$28.4K | +30,465 | New |
|
|
3
Goldman Sachs
New York
| $24K | +$13.4K | +14,321 | New |
|
|
EWM
4
Evercore Wealth Management
New York
| $22K | – | – | – |
|
|
5
Renaissance Technologies
New York
| $19K | +$10.5K | +11,300 | New |
|
|
6
Citadel Advisors
Miami,
Florida
| – | -$7K | -21,347 | Closed |
|
|
7
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | +$73 | +78 | New |
|
AXN Hedge Fund Activity: Q1 2015 in Review
6 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Aoxing Pharmaceutical Company Inc. (AXN) for Q1 2015, worth a combined $195K — up 1,673% from $11K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new AXN positions and 2 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $43.4K. The largest seller was Citadel Advisors, exiting entirely with an estimated $7K sold.
- 6 institutional investors held Aoxing Pharmaceutical Company Inc. (AXN) as of Q1 2015, up from 3 in Q4 2014.
- Funds reported $195K of Aoxing Pharmaceutical Company Inc. stock for Q1 2015, up 1,673% quarter-over-quarter.
- 5 funds opened new Aoxing Pharmaceutical Company Inc. positions in Q1 2015 and 2 closed out, a net change of +3 holders.
- The largest Aoxing Pharmaceutical Company Inc. buyer in Q1 2015 was Virtu KCG Holdings, an estimated $43.4K added.
- The largest Aoxing Pharmaceutical Company Inc. seller in Q1 2015 was Citadel Advisors, an estimated $7K sold.
Based on aggregated 13F filings for Q1 2015.